The data presented at the Type A meeting in September 2023 appears to have changed that:
- CRL in August (data via targeted, controlled study)
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02694227-3A622780
- Type A announcement in September (data via new potency assay)
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02714514-3A626594
- Annual Report to Shareholders in October (confirmation: data via potency assay or clinical data)
https://www.mesoblast.com/images/pdf/MSB_2023_Annual_Report_Online.pdf
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.025(1.47%) |
Mkt cap ! $2.207B | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.73 | $1.64 | $4.189M | 2.480M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31201 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 59276 | 6 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |